Results 31 to 40 of about 20,292 (247)

Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?

open access: yesRMD Open, 2021
Objective Venous thromboembolism (VTE) is an increasing concern in rheumatoid arthritis (RA) with little known about risk factors. We aimed to compare risk factors for unprovoked VTE and atherosclerotic cardiovascular disease (ASCVD) in patients with RA ...
Gulsen Ozen   +4 more
doaj   +1 more source

Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?

open access: yes, 2023
Purpose of Review: Recent large clinical trials have failed to show that triglyceride-rich lipoprotein-lowering therapies decrease the risk of atherosclerotic cardiovascular disease (ASCVD).
Wulff, Anders B.   +7 more
core   +1 more source

First Cardiovascular Event in Rheumatoid Arthritis: Do Patients With Venous Thromboembolism Have a Different Risk Profile Than Patients With Atherosclerotic Cardiovascular Disease?

open access: yesGraduate Medical Education Research Journal, 2020
Mentor: Kaleb Michaud Program: Internal Medicine Type: Original Research Objective: To assess risk factors favoring VTE over ASCVD in patients with rheumatoid arthritis (RA).
Gulsen Ozen   +4 more
doaj   +1 more source

Magnitude, Distribution and Contextual Risk Enhancing Predictors of High 10-Year Cardiovascular Risk Among Diabetic Patients in Tanzania

open access: yesPatient Related Outcome Measures, 2023
Nadeem Kassam,1 Salim Surani,2 Kamran Hameed,3 Eric Aghan,4 Robert Mayenga,1 Iris Matei,1 Gijsberta Jengo,1 Fatma Bakshi,3 Hanifa Mbithe,3 James Orwa,5 George Udeani,2 Samina Somji3 1Department of Internal Medicine, Aga Khan Hospital, Mwanza, Tanzania ...
Kassam N   +11 more
doaj  

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

open access: yesClinical Diabetes and Endocrinology, 2020
Background This study evaluated the impact of atherosclerotic cardiovascular disease (ASCVD) on healthcare resource utilization and costs in patients with type 2 diabetes mellitus (T2DM).
Wayne Weng   +6 more
doaj   +1 more source

A practical approach to the cholesterol guidelines and ASCVD prevention [PDF]

open access: yesCleveland Clinic Journal of Medicine, 2020
Lifestyle factors remain the bedrock of atherosclerotic cardiovascular disease (ASCVD) prevention. Statins remain the first-line therapy for primary and secondary prevention of ASCVD. Physicians are encouraged to discuss the risks and benefits of statins with patients before beginning therapy.
openaire   +2 more sources

Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background High triglycerides are associated with atherosclerotic cardiovascular disease (ASCVD) risks. Among patients with advanced chronic kidney disease (CKD), the association of elevated triglycerides with mortality is diminished and, thus, we ...
Melissa Soohoo   +7 more
doaj   +1 more source

Rethinking “Very High-Risk” ASCVD [PDF]

open access: yesJACC: Advances
Michael D. Shapiro   +9 more
openaire   +3 more sources

Obesity and Atherosclerotic Cardiovascular Disease: A Review of Social and Biobehavioral Pathways

open access: yesMethodist DeBakey Cardiovascular Journal
In the United States, two out of every five adults have obesity. The obesity epidemic is a significant public health concern and a major risk factor for atherosclerotic cardiovascular disease (ASCVD), contributing to its development through a complex ...
Izza Shahid   +7 more
doaj   +1 more source

ASCVD Risk Estimator Plus Utilization: A Quality Improvement Project

open access: yes, 2021
Atherosclerotic cardiovascular disease (ASCVD) is the most common type of heart disease, the leading cause of death in the U.S. The majority of ASCVD risk factors are modifiable, and current guidelines recommend use of an ASCVD 10-year risk estimate to ...
Stanko, Kristie
core  

Home - About - Disclaimer - Privacy